Drug Approval | March 21, 2023
Caplin receives USFDA approval for Rocuronium Bromide Injection
Rocuronium Bromide Injection had an annual sale of approximately US $53 million in the US (IQVIA MAT December 2022)
Rocuronium Bromide Injection had an annual sale of approximately US $53 million in the US (IQVIA MAT December 2022)
Subgroup analysis by HER2 expression from phase 1/2 trial of patients with HER3 expressing metastatic breast cancer highlighted in a second Presidential Session
The antiviral is efficacious in non-human primates, and is safe and well-tolerated in humans
The observations are procedural in nature
The objective of launching these products at AAHAR is to create awareness on the consumption of protein based products
This loan is in addition to earlier announced CAD 25 million loan committed by the Province of Quebec
KRIVIDA TRIVUS detects the specific virus causing a respiratory infection.
MoES have identified a potent Anti-cancer molecule named GS/IICT5/6
Biocorp will receive an initial milestone payment this year
ALPLA is expanding its presence in the global market for pharmaceutical packaging by establishing a joint venture with Inden Pharma
Subscribe To Our Newsletter & Stay Updated
